This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 07/14/2020
Location: Teleconference
Subject: International Dairy Foods Association Priorities
FDA Participant/Group: FRANK YIANNAS; KEAGAN LENIHAN;
Non FDA Participant/Group: Michael Dykes (International Dairy Foods Association);

Event Date: 07/15/2020
Location: Teleconference
Subject: The Economic Club of New York
FDA Participant/Group: STEPHANIE CACCOMO; ALEXANDER WOHL; JOHN WAGNER;
Non FDA Participant/Group: Government, media, industry, academia, and other registered guests

Event Date: 07/16/2020
Location: Teleconference
Subject: 9th Annual Building Resilience Through Private-Public Partnership Conference
FDA Participant/Group: ALEXANDER WOHL; JOHN WAGNER;
Non FDA Participant/Group: Government, media, industry, and other invited guests

Event Date: 07/16/2020
Location: Teleconference
Subject: COVID-19 Vaccines
FDA Participant/Group: PETER MARKS; DAYLE CRISTINZIO; PATRIZIA CAVAZZONI; JOHN WAGNER; CARTER BEACH; LORRIE MCNEILL;
Non FDA Participant/Group: Several industry groups affiliated with Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Innovation Organization (BIO)

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 07/13/2020
Location: Virtual
Subject: National Cancer Policy Forum Workshop: Opportunities and Challenges for Using Digital Health Applications in Oncology Fireside Chat
FDA Participant/Group: ANAND SHAH; PAUL KLUETZ;
Non FDA Participant/Group: Academia, industry, patient groups, other government, and other stakeholders

Event Date: 07/13/2020
Location: Virtual
Subject: Duke-Margolis Center for Health Policy Workshop: Establishing a High-Quality Real-World Data Ecosystem
FDA Participant/Group: JACQUELINE CORRIGAN CURAY;
Non FDA Participant/Group: Academia, industry, other federal government, and other stakeholders

Event Date: 07/16/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, health care providers, industry, academia, and other stakeholders

Event Date: 07/17/2020
Location: Virtual
Subject: NESTcc Cloud Infrastructure System Discussion
FDA Participant/Group: WILLIAM STEVENSON; MIMI NGUYEN; JOSEPH FRANKLIN; VIDYUT DESAI; SEAN TUNIS; LAURA ROE; RAM IYER; CRAIG TAYLOR;
Non FDA Participant/Group: Daniel Zagales, Erik Willsey, Steve Jones (Pandera Systems); Carol Allis, Jordan Hirsch, Robbert Zusterzeel (MDIC/NESTcc); Alex Hanson, Alexandra Cha, Mattie Whitmore (Booz Allen Hamilton);

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 07/15/2020
Location: Webinar
Subject: Alexandria Summit - Immunology 2020 - Keynote Address: Regulation and Innovation – An FDA Perspective
FDA Participant/Group: JANET WOODCOCK; ANAND SHAH;
Non FDA Participant/Group: Senior leaders from academia, biopharma industry, patient advocacy groups, and other stakeholders

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: John Wagner, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/14/2020
Location: Virtual
Subject: America's Blood Centers (ABC): Presentation - Pulse from FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Blood centers and transfusion medicine community members

Event Date: 07/14/2020
Location: Virtual
Subject: FDA Perspective on Addressing Quality Manufacturing Capacity for Advanced Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Advanced therapies stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/16/2020
Location: Virtual
Subject: Life Sciences Future – MedTech: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Mark Leahey (Medical Device Manufacturers Association);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event